FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ENvue Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026
- Market cap
- $3.08M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$70.0000 (−99.29%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
ENvue Medical, Inc. saw revenue fall 17.7% to $1.93M over the twelve months to Jun 30, 2026. Free cash flow was -$11.74M.
Revenue
$1.93M
-17.7% vs. a year earlier
Operating income
-$26.25M
TTM Q2 2026
Free cash flow
-$11.74M
TTM Q2 2026
EPS, diluted
-$26.69
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.08M
- P/E ratio
- –
- Price to sales
- 1.60
- Price to book
- 0.10
- Dividend yield
- –
- Free cash flow yield
- -381.47%
Fundamentals
- Revenue
- $1.93M
- Net income
- -$21.06M
- EPS, diluted
- -$26.69
- Free cash flow
- -$11.74M
- Book value per share
- $5.00
- Diluted shares
- 6M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$1.93M-17.7% YoY
Gross profit
-$502.00K-166.9% YoY
Operating income
-$26.25M
Net income
-$21.06M
EPS, diluted
–
Free cash flow
-$11.74M
Reported periodTrailing twelve months